Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer

被引:249
作者
Ruggiero, Salvatore [1 ]
Gralow, Julie
Marx, Robert E.
Hoff, Ana O.
Schubert, Mark M.
Huryn, Joseph M.
Toth, Bela
Damato, Kathryn
Valero, Vicente
机构
[1] Long Isl Jewish Med Ctr, 270-05 76th Ave, New Hyde Pk, NY 11040 USA
关键词
D O I
10.1200/JOP.2.1.7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This article discusses osteonecrosis of the jaw (ONJ) and offers health care professionals practical guidelines and recommendations for the prevention, diagnosis, and management of ONJ in cancer patients receiving bisphosphonate treatment. Methods: A panel of experts representing oral and maxillofacial surgery, oral medicine, endocrinology, and medical oncology was convened to review the literature and clinical evidence, identify risk factors for ONJ, and develop clinical guidelines for the prevention, early diagnosis, and multidisciplinary treatment of ONJ in patients with cancer. The guidelines are based on experience and have not been evaluated within the context of controlled clinical trials. Results: ONJ is a clinical entity with many possible etiologies; historically identified risk factors include corticosteroids, chemotherapy, radiotherapy, trauma, infection, and cancer. With emerging concern for potential development of ONJ in patients receiving bisphosphonates, the panel recommends a dental examination before patients begin therapy with intravenous bisphosphonates. Dental treatments and procedures that require bone healing should be completed before initiating intravenous bisphosphonate therapy. Patients should be instructed on the importance of maintaining good oral hygiene and having regular dental assessments. For patients currently receiving bisphosphonates who require dental procedures, there is no evidence to suggest that interrupting bisphosphonate therapy will prevent or lower the risk of ONJ. Frequent clinical assessments and conservative dental management are suggested for these patients. For treatment of patients who develop ONJ, a conservative, nonsurgical approach is strongly recommended. Conclusion: An increased awareness of the potential risk of ONJ in patients receiving bisphosphonate therapy is needed. Close coordination between the treating physician and oral surgeon and/or a dental specialist is strongly recommended in making treatment decisions.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 57 条
[1]  
Arico M, 2003, HAEMATOLOGICA, V88, P747
[2]   Mandibular alveolar bone necrosis after trigeminal herpes zoster [J].
Arikawa, J ;
Mizushima, J ;
Higaki, Y ;
Hoshino, J ;
Kawashima, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (02) :136-137
[3]   New foundations in understanding osteonecrosis of the jaws [J].
Assael, LA .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (02) :125-126
[4]  
Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724
[5]   Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases [J].
Bagan, JV ;
Murillo, J ;
Jimenez, Y ;
Poveda, R ;
Milian, MA ;
Sanchis, JM ;
Silvestre, FJ ;
Scully, C .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (02) :120-123
[6]   American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma [J].
Berenson, JR ;
Hillner, BE ;
Kyle, RA ;
Anderson, K ;
Lipton, A ;
Yee, GC ;
Biermann, JS .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3719-3736
[7]   Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, M ;
Blacklock, H ;
Bell, R ;
Simeone, JF ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :593-602
[8]   OSTEORADIONECROSIS OF THE MANDIBLE - PATHOGENESIS [J].
BRAS, J ;
DEJONGE, HKT ;
VANMERKESTEYN, JPR .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1990, 11 (04) :244-250
[9]   Bisphosphonates and avascular necrosis of the jaw: a possible association [J].
Carter, G ;
Goss, AN ;
Doecke, C .
MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (08) :413-415
[10]   Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs [J].
Drescher, W ;
Weigert, KP ;
Bünger, MH ;
Ingerslev, J ;
Bünger, C ;
Hansen, ES .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2004, 22 (03) :501-508